Afshin Veiseh, MD
NPI 1205807146 · General Practice Physician · Beverly Hills, CA
Enrolled with Medicare as Practitioner - Internal Medicine · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Afshin Veiseh, MD is a General Practice Physician provider in Beverly Hills, CA (NPI 1205807146).
Provider details
- NPI number
- 1205807146
- Entity type
- Individual
- Primary specialty
- General Practice PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- G74878 (CA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
8,913 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 745 | $98 |
| Albumin (protein) Level82040 | 224 | $5 |
| Bilirubin Level, Total82247 | 224 | $5 |
| Calcium Level, Total82310 | 224 | $5 |
| Carbon Dioxide (bicarbonate) Level82374 | 224 | $5 |
| Blood Creatinine Level82565 | 224 | $5 |
| Glutamyltransferase (liver Enzyme) Level82977 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 45 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Atorvastatin Calcium | 184 | 53 |
| Tirzepatidebrand: Mounjaro | 107 | 13 |
| Zolpidem Tartrate | 68 | 18 |
| Rosuvastatin Calcium | 64 | 19 |
| Amlodipine Besylate | 63 | 19 |
| Losartan/Hydrochlorothiazidebrand: Losartan-Hydrochlorothiazide | 56 | 13 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$285 across 11 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-01-30
- Last updated
- 2026-03-27
- Certified
- 2026-03-27
Frequently asked questions
- What is Afshin Veiseh's NPI number?
- Afshin Veiseh's National Provider Identifier (NPI) is 1205807146, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Afshin Veiseh's specialty?
- Afshin Veiseh is listed in the NPPES registry with a primary specialty of General Practice Physician (Allopathic & Osteopathic Physicians).
- Where is Afshin Veiseh located?
- Afshin Veiseh's practice location on file with NPPES is 8900 Wilshire Blvd Ste 360, Beverly Hills, CA 90211-2019.
- What is Afshin Veiseh's phone number?
- The practice phone number listed in the NPPES registry for Afshin Veiseh is (310) 209-2098.
- Does Afshin Veiseh accept Medicare?
- Afshin Veiseh is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Afshin Veiseh's NPI active?
- Yes — Afshin Veiseh's NPI (1205807146) is active in the NPPES registry as of the last update on 2026-03-27.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.